Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for BioRestorative Therapies (BRTX) over the last 13 years, with Q2 2025 value amounting to $1.1 million.

  • BioRestorative Therapies' Total Non-Current Liabilities rose 3177.42% to $1.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.1 million, marking a year-over-year increase of 3177.42%. This contributed to the annual value of $1.2 million for FY2024, which is 1543.77% up from last year.
  • Latest data reveals that BioRestorative Therapies reported Total Non-Current Liabilities of $1.1 million as of Q2 2025, which was up 3177.42% from $1.0 million recorded in Q1 2025.
  • Over the past 5 years, BioRestorative Therapies' Total Non-Current Liabilities peaked at $1.3 million during Q1 2024, and registered a low of $602619.0 during Q4 2022.
  • For the 4-year period, BioRestorative Therapies' Total Non-Current Liabilities averaged around $1.0 million, with its median value being $1.1 million (2023).
  • In the last 5 years, BioRestorative Therapies' Total Non-Current Liabilities skyrocketed by 7646.17% in 2023 and then plummeted by 1840.04% in 2025.
  • Over the past 4 years, BioRestorative Therapies' Total Non-Current Liabilities (Quarter) stood at $602619.0 in 2022, then surged by 76.46% to $1.1 million in 2023, then grew by 15.44% to $1.2 million in 2024, then dropped by 11.14% to $1.1 million in 2025.
  • Its Total Non-Current Liabilities stands at $1.1 million for Q2 2025, versus $1.0 million for Q1 2025 and $1.2 million for Q4 2024.